Search - tctmd.com

Displaying 21 - 40 of 82

Sort: Relevancy | Date

News Conference News TCT 2021

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Michael O'Riordan

November 05, 2021

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

News Conference News TCT 2021

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

Caitlin E. Cox

November 04, 2021

News Conference News TCT 2021

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

Michael O'Riordan

October 07, 2021

News Conference News TCT 2020

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Michael O'Riordan

October 23, 2020

News Conference News TCT 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Shelley Wood

October 17, 2020

News Conference News TCT 2020

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Michael O'Riordan

October 16, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

Presentation TCT 2020

Grading FMR Severity: Evolution of the Concept and Evolving Data

Presenter: Paul Grayburn

October 14, 2020

News Conference News TCT 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Michael O'Riordan

October 07, 2019

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Todd Neale

October 04, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

Presentation TCT 2019

The (R)evolution of Image-based FFR – Introducing the CathWorks FFRangio System

Presenter: Bruce Samuels

September 27, 2019

Presentation TCT 2019

Keynote Lecture: A Vision for an Evolving Regulatory and Healthcare System

Presenter: Robert Califf

September 26, 2019

Presentation TCT 2019

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

Presenter: Saibal Kar

September 26, 2019

Presentation TCT 2019

Keynote Lecture: New Technology Assessment and Reimbursement Synergy — Forward Strides

Presenter: Lori Ashby

September 26, 2019

Presentation TCT 2019

Keynote Lecture: FDA/CDRH — The Year in Review, Focus on CDRH’s Total Product Life Cycle Concept

Presenter: William Maisel

September 26, 2019

News Conference News TCT 2019

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Michael O'Riordan

September 25, 2019

Presentation TCT 2019

COAPT, Partner 2, and Evolut Low-Risk Trial Synopsis and What They Mean Moving Forward

Presenter: Elizabeth Perpetua

September 25, 2019

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

Advertisement

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Grading FMR Severity: Evolution of the Concept and Evolving Data

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

The (R)evolution of Image-based FFR – Introducing the CathWorks FFRangio System

Keynote Lecture: A Vision for an Evolving Regulatory and Healthcare System

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

Keynote Lecture: New Technology Assessment and Reimbursement Synergy — Forward Strides

Keynote Lecture: FDA/CDRH — The Year in Review, Focus on CDRH’s Total Product Life Cycle Concept

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

COAPT, Partner 2, and Evolut Low-Risk Trial Synopsis and What They Mean Moving Forward

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content